Brain metastasis is the most common intracranial tumor, resulting from hematogenous spread of a systemic malignancy to the brain parenchyma. It is 10 times more common than primary brain tumors. The most common primary sources are lung (40-50%), breast (15-25%), melanoma (5-20%), renal cell carcinoma (5-10%), and colorectal cancer (3-5%). Typically characterized by lesions at the gray-white matter junction, multiple in number, with peritumoral edema disproportionate to lesion size. Solitary metastasis occurs in 30-40% of cases.
Age Range
40-80
Peak Age
60
Gender
Equal
Prevalence
Very Common
Brain metastasis occurs through the hematogenous route; tumor cells reach the cerebral vascular bed via arterial circulation. At the gray-white matter junction, the sudden narrowing of vessel caliber causes tumor emboli to become lodged, making this the most common metastatic site. Tumor cells cross the blood-brain barrier to establish colonies in brain parenchyma and induce local neoangiogenesis. The newly formed vessels of metastatic tumor have a disrupted blood-brain barrier, leading to contrast enhancement. Marked vasogenic edema surrounding the tumor is disproportionate to tumor size and is related to vascular endothelial growth factor (VEGF) release. Metastases are generally well-circumscribed and do not infiltrate brain parenchyma — this is the fundamental difference from gliomas.
Multiple enhancing lesions at the gray-white matter junction with marked vasogenic edema disproportionate to lesion size is the most characteristic imaging finding of brain metastasis. This pattern reflects lodging of arterial tumor emboli where vessel caliber narrows at the junction and disproportionate edema formation through VEGF release. Combined with a known primary malignancy history, these findings are considered diagnostic.
On non-contrast CT, multiple iso-to-hypodense lesions at the gray-white matter junction are observed. Hemorrhagic metastases (melanoma, RCC, choriocarcinoma) may appear hyperdense. Marked peritumoral edema appears as hypodense areas in surrounding parenchyma. Mass effect with ventricular compression and midline shift may be seen. CT has lower sensitivity than MRI for metastasis screening — especially small (<5mm) and posterior fossa lesions may be missed.
Report Sentence
Multiple iso-to-hypodense lesions are identified at the gray-white matter junction in both cerebral hemispheres, the largest measuring _x_ cm in the ___ region, with marked peritumoral edema and mass effect.
On T1 post-contrast sequences, multiple enhancing lesions at the gray-white matter junction are observed. Enhancement pattern varies by primary tumor type: solid homogeneous (breast, melanoma), ring-like (lung, colorectal), nodular (RCC). Small lesions show homogeneous enhancement, while larger lesions show ring enhancement with central necrosis. Contrast-enhanced MRI is the gold standard for brain metastasis detection — triple-dose gadolinium or delayed imaging (15-20 min) increases sensitivity. Leptomeningeal carcinomatosis appears as diffuse meningeal enhancement.
Report Sentence
On T1 post-contrast sequences, multiple enhancing lesions are identified at the gray-white matter junction, the largest measuring _x_ cm in the ___ region with marked surrounding vasogenic edema. Findings are consistent with metastatic disease.
On T2-weighted sequences, lesions show variable signal intensity — hyperintense for most primary sources, iso-to-hypointense for melanoma metastasis (paramagnetic effect of melanin). The most striking finding is marked vasogenic edema disproportionate to lesion size — even a small metastasis may be surrounded by extensive T2 hyperintense edema. This disproportionate edema is related to VEGF release. Edema shows finger-like extension along white matter (vasogenic edema pattern). T2 hypointense hemosiderin rims may be seen in hemorrhagic metastases.
Report Sentence
On T2-weighted sequences, lesions demonstrate hyperintense signal with marked peritumoral vasogenic edema disproportionate to lesion size.
On FLAIR sequences, peritumoral vasogenic edema is most conspicuously visualized. Edema shows finger-like extension along white matter tracts and typically does not involve cortical gray matter (vasogenic edema pattern). Importantly, FLAIR abnormality is confined to the borders of the enhancing lesion and does not extend beyond — this is the key distinguishing feature from GBM (where FLAIR abnormality extends beyond enhancement — non-enhancing tumor). Leptomeningeal metastasis may appear as sulcal hyperintensity on FLAIR.
Report Sentence
On FLAIR sequences, marked vasogenic edema extending along white matter is observed around the lesions, with FLAIR abnormality corresponding to the borders of the enhancing lesions.
Diffusion restriction in metastases varies depending on primary tumor type. Highly cellular metastases (small cell lung cancer, lymphoma-derived) show marked diffusion restriction. Adenocarcinoma metastases generally show moderate restriction. Central areas of necrotic metastases show facilitated diffusion (high ADC). Critical in abscess differential: metastasis necrotic cavity shows facilitated diffusion (high ADC), while abscess shows restricted diffusion (low ADC). ADC values are also used in treatment response monitoring — ADC increase is expected with effective treatment.
Report Sentence
On DWI, variable degrees of diffusion restriction are observed in the solid components of the lesions, with ADC values of ___ x10⁻³ mm²/s.
The most important feature of metastases on perfusion MRI is normal rCBV values in the peritumoral area. This finding reflects the non-infiltrative nature of metastasis — no tumor infiltration exists in the peritumoral edema zone. This is the most valuable perfusion finding for differentiation from GBM; elevated peritumoral rCBV in GBM indicates infiltrative tumor spread. Intratumoral rCBV varies by primary tumor type — renal metastases and melanoma typically show very high rCBV. rCBV ratio of metastasis/normal white matter is usually in the 1.5-3.0 range.
Report Sentence
Perfusion MRI demonstrates elevated intratumoral rCBV in the lesions, while peritumoral rCBV values are within normal limits — consistent with non-infiltrative tumor.
On SWI sequences, hemorrhagic metastases show prominent susceptibility foci. Primary tumors with hemorrhagic tendency: melanoma, renal cell carcinoma, choriocarcinoma, thyroid cancer, and bronchogenic carcinoma. SWI can detect many more microhemorrhages and occult lesions compared to conventional sequences. Multiple susceptibility foci in the presence of known malignancy is a strong finding favoring metastasis. SWI may also help differentiate radiation-induced changes (radiation necrosis) from metastasis recurrence.
Report Sentence
On SWI sequences, prominent susceptibility foci consistent with hemorrhagic components are observed within the lesions.
MR spectroscopy of metastases shows elevated choline (cell membrane turnover), reduced NAA (neuronal destruction), and variable lipid-lactate peaks. Compared to GBM, choline/creatine ratio is generally lower in metastases. MRS of the peritumoral area is highly valuable: metastasis peritumoral zone shows normal metabolite profile, while GBM peritumoral area shows elevated choline (infiltrative tumor). Mucinous metastases (colorectal) may show markedly high lactate.
Report Sentence
MR spectroscopy shows elevated choline and reduced NAA in the lesion, with normal metabolite profile in the peritumoral area — consistent with non-infiltrative tumor.
Criteria
Metastasis containing intratumoral hemorrhage. Most commonly from melanoma, RCC, choriocarcinoma, thyroid, and bronchogenic carcinoma. Hyperdense on CT, T1 hyperintense (methemoglobin) on MRI, prominent susceptibility on SWI.
Distinct Features
Spontaneous T1 hyperintensity (methemoglobin), multiple blooming artifacts on SWI, fluid-fluid level (acute hemorrhage), early enhancement due to blood-brain barrier disruption. Melanoma metastasis is T1 hyperintense and T2 hypointense due to melanin.
Criteria
Metastasis with prominent central necrosis or cystic degeneration. Shows ring-like enhancement. Most commonly from lung squamous cell carcinoma and colorectal cancer.
Distinct Features
Thin and smooth ring enhancement (thick and irregular in GBM), facilitated diffusion in necrotic cavity (high ADC — unlike abscess), low signal within cavity on DWI. DWI is critical in differential diagnosis with abscess.
Criteria
Metastasis form characterized by spread to leptomeninges (pia-arachnoid). Most commonly from breast, lung, and melanoma. CSF cytology is diagnostic. Diffuse leptomeningeal enhancement on MRI.
Distinct Features
Diffuse thin meningeal enhancement on T1 post-contrast (not dura — pachymeningeal involvement is different), cranial nerve enhancement, sulcal hyperintensity on FLAIR, communicating hydrocephalus, tumor cells in CSF.
Distinguishing Feature
GBM: usually solitary large lesion, thick irregular ring enhancement, elevated peritumoral rCBV (infiltrative), FLAIR abnormality extends beyond enhancement, may involve corpus callosum. Metastasis: usually multiple, disproportionate edema, normal peritumoral rCBV, FLAIR abnormality confined to enhancing area.
Distinguishing Feature
Abscess: thin smooth ring enhancement, restricted diffusion within cavity (DWI bright), amino acid peaks on MRS, fever and infection signs. Metastasis: facilitated diffusion within cavity (DWI dark), elevated choline on MRS, known malignancy history.
Distinguishing Feature
Primary CNS lymphoma: typically periventricular, homogeneous enhancement, markedly restricted diffusion (very low ADC), low rCBV, steroid response. Metastasis: at gray-white junction, multiple, disproportionate edema, variable diffusion, no steroid response.
Distinguishing Feature
Toxoplasmosis: immunosuppressed patient (HIV), basal ganglia predilection, eccentric target sign, low rCBV, response to anti-toxoplasma treatment. Metastasis: immunocompetent, gray-white junction, known malignancy, no treatment response.
Urgency
urgentManagement
Tedavi seçenekleri lezyon sayısı, boyutu ve primer tümör durumuna göre belirlenir. Soliter metastaz: cerrahi rezeksiyon + adjuvan WBRT veya SRS. 1-3 lezyon (≤3cm): SRS (stereotaktik radyocerrahi). Multipl (>3): WBRT (tüm beyin radyoterapisi) veya immünoterapi. Sistemik tedavi (kemoterapi, hedefe yönelik tedavi, immünoterapi) primer tümör tipine göre.Biopsy
NeededFollow-up
Tedavi sonrası her 2-3 ayda kontrastlı MRG. Radyonekroz vs. rekürrens ayırıcı tanısında perfüzyon MRG ve PET-BT kullanılır. İntrakraniyal progresyonda SRS, cerrahi veya sistemik tedavi değişikliği değerlendirilir.Brain metastasis is an oncologic emergency requiring a multidisciplinary approach. Treatment planning depends on primary tumor type, lesion number/size, systemic disease status, and patient performance status. Surgical resection of solitary large metastases both reduces mass effect and provides histological diagnosis. Stereotactic radiosurgery (SRS) offers superior neurocognitive outcomes compared to WBRT for small and limited number of lesions. Immune checkpoint inhibitors have shown impressive intracranial response rates, particularly in melanoma metastases.
Brain metastasis indicates advanced-stage disease and is a major prognostic determinant. Treatment options include surgery (single or oligometastases), stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and systemic therapy. Control of the primary tumor and extent of systemic disease guide treatment decisions.